Price$472.71-40.44 (-7.88%)
2026-03-042026-06-05
News · 26 weeks84+89%
2025-12-142026-06-07
Mix4190d
- Insider18(44%)
- Other9(22%)
- SEC Filings7(17%)
- Analyst4(10%)
- Earnings2(5%)
- Leadership1(2%)
Latest news
25 items- ANALYSTThermo Fisher downgraded by HSBC Securities with a new price targetHSBC Securities downgraded Thermo Fisher from Buy to Hold and set a new price target of $540.00
- ANALYSTWolfe Research resumed coverage on Thermo Fisher with a new price targetWolfe Research resumed coverage of Thermo Fisher with a rating of Outperform and set a new price target of $535.00
- SECSEC Form SD filed by Thermo Fisher Scientific IncSD - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRThermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New TherapiesNew mass spectrometry platforms, combined with AI-driven analytics and scalable proteomics solutions, help scientists turn complex biology into actionable insights across research and drug development Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face increasing pressure to generate hi
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- INSIDERDirector Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Johnson Jennifer M was granted 499 shares, increasing direct ownership by 55% to 1,403 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Jacks Tyler was granted 499 shares, increasing direct ownership by 6% to 9,462 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Harris C Martin was granted 499 shares, increasing direct ownership by 6% to 9,532 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Chandy Ruby R was granted 499 shares, increasing direct ownership by 17% to 3,463 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- INSIDERDirector Chai Nelson was granted 499 shares, increasing direct ownership by 3% to 15,316 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- PRThermo Fisher Scientific Announces Quarterly DividendThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the developm
- PRThermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor DayThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company's industry leadership and the essential role of its best-in-class products and services to customers around the world. "Our customers value Thermo Fisher as their trusted partner," said Marc N. Casper, chairman and chief executive officer, Thermo Fisher Scientific. "Our unique scale and depth of capabilities advance scientific discovery and position us incredibly well in an increasingly AI-enabled world." Casper continued, "We have a track record of delivering sh
- ANALYSTRBC Capital Mkts resumed coverage on Thermo Fisher with a new price targetRBC Capital Mkts resumed coverage of Thermo Fisher with a rating of Sector Perform and set a new price target of $490.00
- SECSEC Form DEFA14A filed by Thermo Fisher Scientific IncDEFA14A - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- PRTerrestrial Energy Appoints Tyler Gronbach as Vice President of Investor Relations and Public RelationsSeasoned external affairs executive to lead investor and public communications as company advances IMSR commercialization Terrestrial Energy Inc. (NASDAQ:IMSR) ("Terrestrial Energy" or the "Company"), a developer of proprietary Generation IV small modular nuclear power plants, today announced that Tyler Gronbach has joined the company as Vice President of Investor Relations and Public Relations. The appointment comes as Terrestrial Energy accelerates commercialization of its Integral Molten Salt Reactor (IMSR) and expands engagement with institutional investors, sell-side analysts and the financial media following its Nasdaq listing last year. Gronbach will report to CEO Simon Irish and
- SECSEC Form 10-Q filed by Thermo Fisher Scientific Inc10-Q - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
- INSIDERPresident & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)4 - THERMO FISHER SCIENTIFIC INC. (0000097745) (Issuer)
- PRThermo Fisher Scientific to Host Investor DayThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City. The format will feature presentations by members of Thermo Fisher Scientific's senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, https://ir.thermofisher.com. A replay of the webcast will be available following the presentation. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to
- PRThermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to AstorgThermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing. The business generated $645 million in revenue in 2025 and is part of Thermo Fisher's Specialty Diagnostics segment. "The transaction reflects our active management of the company and provides additional capital we
- SECThermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - THERMO FISHER SCIENTIFIC INC. (0000097745) (Filer)
TMO FAQ
6 questionsWhat does Thermo Fisher Scientific Inc do?
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in...Where does TMO stock trade?
Thermo Fisher Scientific Inc (TMO) is listed on NYSE.What sector and industry is TMO in?
Thermo Fisher Scientific Inc operates in the Industrials sector, Industrial Machinery/Components industry.What are analysts saying about TMO?
Thermo Fisher Scientific Inc has had 8 recent analyst actions on file. The most recent action was from HSBC Securities: Hold on 2026-06-03.What companies are similar to TMO?
Notable peers in the same industry include ASML (ASML Holding N.V. New York Registry Shares), LRCX (Lam Research Corporation), DE (Deere & Company), ETN (Eaton Corporation PLC), DHR (Danaher Corporation). Compare TMO side-by-side with any of them on Quantisnow.How can I track TMO on Quantisnow?
Quantisnow aggregates Thermo Fisher Scientific Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TMO to receive live email and push alerts on every new disclosure.